Myovant Sciences Ltd

NYSE:MYOV  
13.28
-0.49 (-3.56%)
Products

Myovant Sciences And Pfizer Announce FDA Acceptance Of Supplemental New Drug Application For Myfembree

Published: 06/02/2022 10:59 GMT
Myovant Sciences Ltd (MYOV) - Myovant Sciences and Pfizer Announce FDA Acceptance of Supplemental New Drug Application for Myfembree®.
Myovant Sciences Ltd - FDA Set a Target Action Date of January 29, 2023 for This Snda Under Prescription Drug User Fee Act.